Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives

Cancers

Khe Hoang-Xuan¹  Caroline Houillier¹  Andrea Morales-Martinez¹  Alberto Duran-Peña¹  Fernando Lozano-Sanchez¹ 

[1] APHP, Groupe Hospitalier Salpêtrière, Sorbonne Université, IHU, ICM, Service de Neurologie 2-Mazarin, 75013 Paris, France;

关键词: primary CNS lymphoma;    elderly;    chemotherapy;    immunotherapy;   

DOI  :  10.3390/cancers13143479

来源: DOAJ

【 摘 要 】

The management of elderly patients suffering from primary central nervous system (CNS) lymphoma, who represent a rapidly growing population, is challenging. Despite the advances made in PCNSL treatment, the prognosis in older patients remains unsatisfactory. The high risk of systemic and CNS toxicity induced by a high-dose chemotherapy regimen and radiation therapy, respectively, limits the use of consolidation phase treatments in elderly patients and contributes to the poor outcome of these patients. Here, we review the current treatment strategies and ongoing trials proposed for elderly PCNSL patients.

【 授权许可】

Unknown